Checkpoint Therapeutics Correlations

CKPT Stock

USD 2.83 0.05 1.80%

The current 90-days correlation between Checkpoint Therapeutics and Reviva Pharmaceuticals Holdings is -0.15 (i.e., Good diversification). The correlation of Checkpoint Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Checkpoint Therapeutics Correlation With Market

Significant diversification

The correlation between Checkpoint Therapeutics and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Checkpoint Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Checkpoint Stock please use our How to Invest in Checkpoint Therapeutics guide.

Moving together with Checkpoint Stock

0.68	INZY	Inozyme Pharma	Pair Corr
0.75	ABOS	Acumen Pharmaceuticals	Pair Corr
0.8	ADTX	Aditxt Inc	Pair Corr
0.76	STRO	Sutro Biopharma	Pair Corr
0.79	TCRX	Tscan Therapeutics	Pair Corr
0.78	TERN	Terns Pharmaceuticals	Pair Corr
0.78	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.74	CTMX	CytomX Therapeutics	Pair Corr
0.67	DAWN	Day One Biopharmaceu	Pair Corr

Moving against Checkpoint Stock

0.58	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.55	PHGE	Biomx Inc	Pair Corr
0.54	OPT	Opthea	Pair Corr
0.48	GANX	Gain Therapeutics	Pair Corr
0.48	LTRN	Lantern Pharma	Pair Corr
0.44	CUE	Cue Biopharma	Pair Corr
0.34	A	Agilent Technologies	Pair Corr
0.65	CGTX	Cognition Therapeutics	Pair Corr
0.5	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.74	OBI	Ondine Biomedical	Pair Corr
0.74	SSNLF	Samsung Electronics	Pair Corr
0.48	EC	Ecopetrol SA ADR	Pair Corr
0.43	GPI	Group 1 Automotive	Pair Corr

Related Correlations Analysis

	MBIO	RVPH	FBIOP	KOD	FBIO	ATXI	PIRS	ALRN	CTMX	TIL
MBIO		-0.11	-0.09	0.64	0.55	0.86	0.0	0.0	0.72	0.19	MBIO
RVPH	-0.11		0.64	0.31	0.28	-0.19	0.0	0.0	0.11	-0.35	RVPH
FBIOP	-0.09	0.64		0.5	0.53	-0.11	0.0	0.0	0.26	-0.35	FBIOP
KOD	0.64	0.31	0.5		0.69	0.64	0.0	0.0	0.72	-0.13	KOD
FBIO	0.55	0.28	0.53	0.69		0.5	0.0	0.0	0.71	0.07	FBIO
ATXI	0.86	-0.19	-0.11	0.64	0.5		0.0	0.0	0.62	0.21	ATXI
PIRS	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	PIRS
ALRN	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	ALRN
CTMX	0.72	0.11	0.26	0.72	0.71	0.62	0.0	0.0		0.3	CTMX
TIL	0.19	-0.35	-0.35	-0.13	0.07	0.21	0.0	0.0	0.3		TIL
	MBIO	RVPH	FBIOP	KOD	FBIO	ATXI	PIRS	ALRN	CTMX	TIL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ATXI	+ 0.86	MBIO
CTMX	+ 0.72	MBIO
CTMX	+ 0.72	KOD
CTMX	+ 0.71	FBIO
FBIO	+ 0.69	KOD
KOD	+ 0.64	MBIO

High negative correlations

TIL	- 0.35	FBIOP
TIL	- 0.35	RVPH
ATXI	- 0.19	RVPH
TIL	- 0.13	KOD
ATXI	- 0.11	FBIOP
RVPH	- 0.11	MBIO

Risk-Adjusted Indicators

There is a big difference between Checkpoint Stock performing well and Checkpoint Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Checkpoint Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MBIO	5.60	(1.73)	0.00	0.38	0.00	0.00	15.38	(13.15)	53.88
RVPH	6.04	0.56	0.06	0.18	8.59	(6.77)	15.38	(10.67)	67.62
FBIOP	2.74	0.29	0.10	(0.41)	2.79	(3.31)	7.44	(4.44)	21.73
KOD	5.07	(0.22)	0.00	(0.12)	0.00	0.00	10.44	(9.57)	45.02
FBIO	3.25	0.10	0.03	6.18	3.02	(4.78)	9.76	(5.50)	24.02
ATXI	3.59	(0.57)	0.00	(0.47)	0.00	0.00	6.74	(7.33)	31.48
PIRS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ALRN	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CTMX	3.85	(0.29)	0.00	(0.14)	0.00	0.00	7.32	(7.45)	23.37
TIL	5.75	(0.13)	0.00	(0.05)	0.00	0.00	14.84	(9.64)	33.50

Checkpoint Therapeutics Corporate Executives

Elected by the shareholders, the Checkpoint Therapeutics' board of directors comprises two types of representatives: Checkpoint Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Checkpoint. The board's role is to monitor Checkpoint Therapeutics' management team and ensure that shareholders' interests are well served. Checkpoint Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Checkpoint Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

	William Gray	Corporate CFO	Profile
	William CPA	Corporate CFO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC